No, won't do that this year but EBITDA will remain consistent around $135-150M witha view of $200-220M in 2021 thats not even factoring in generic drug pricing upswings.
Book value is 80c and if a take over will eventuate won't occur sub 75c. Sentiment around generic pricing is the elephant in the room.
This is an economy of scale issue and whether generic drug pricing will rebound. No different to gold stocks when POG is in the doldrums except a viable price index on generic drugs is almost non existent. Not expecting much until late in the year... October/November is when trading updates are released for HY results and one does expect generic drug pricing to rebound by then.
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma market update
Ann: Mayne Pharma market update, page-182
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.47 |
Change
-0.030(0.67%) |
Mkt cap ! $380.2M |
Open | High | Low | Value | Volume |
$4.50 | $4.52 | $4.43 | $419.5K | 93.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 89 | $4.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.52 | 473 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 89 | 4.470 |
1 | 473 | 4.460 |
1 | 473 | 4.450 |
1 | 473 | 4.440 |
1 | 2000 | 4.420 |
Price($) | Vol. | No. |
---|---|---|
4.520 | 473 | 1 |
4.530 | 477 | 2 |
4.540 | 473 | 1 |
4.550 | 477 | 2 |
4.570 | 1088 | 1 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online